Proposed rule - Federal Register
HHS (including the HHS?OIG or CMS) or the Department of Justice due to an allegation of fraud or significant misconduct, including being ...
Federal Register/Vol. 87, No. 220/Wednesday, November 16, 2022 ...Under the OTC drug review process, a nonprescription drug product may be marketed without an application approved under section 505 of the FD&C. Medicare Program; Hospital Inpatient Prospective Payment Systems ...FOR FURTHER INFORMATION CONTACT: Donald Thompson, and Michele Hudson,. (410) 786-4487 or DAC@cms.hhs.gov, Operating Prospective Payment, MS-DRG ... 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES ...In the current select agent regulations, in order for clinical or diagnostic laboratories to maintain their exemption under 42 CFR 73.5 (a), and ...
Autres Cours:
